Table 1.
Baseline patient characteristics
| Item | Value |
| Patients (n) | 23 |
| Age (years) | 69.7±8.3 |
| Female (%) | 34.8 |
| Systolic BP (mm Hg) | 107.5±25.9 |
| Diastolic BP (mm Hg) | 69.8±18.2 |
| Heart rate (beats per minute) | 83.6±20.1 |
| SPO2 (%) | 86.4±11.3 |
| Blood biochemistry | |
| CK (peak, u/L) | 2011.9±2418.3 |
| CKMB (peak, u/L) | 168.1±199.3 |
| RBC (×109/L) | 4.1±0.6 |
| PLT (×109/L) | 180.7±58.7 |
| Creatine (µmol/L) | 88.7±24.9 |
| Death (%) | 73.9 |
| Early rupture (%) | 52.2 |
| Late rupture (%) | 34.8 |
| Ultrasonic cardiogram | |
| LVEDD (mm) | 54.3±5.2 |
| LVESD (mm) | 39.3±6.3 |
| EF (%) | 52.4±9.6 |
| Hypertension (%) | 52.2 |
| Diabetes (%) | 17.4 |
| Cerebral infarction (%) | 17.4 |
| CKD (%) | 0.0 |
| COPD (%) | 4.2 |
| STEMI | 18 (78.3%) |
| Anterior | 9 |
| Inferior posterior | 3 |
| High lateral | 3 |
| Inferior and right ventricle | 3 |
| NSTEMI | 5 (21.7%) |
| Mean time to revascularization (hours) | 50.5 |
| Patency rate of IRA (%) | 43.5 |
| Surgery | 3 (13.0%) |
| IABP (%) | 8.3 |
| Aspirin (%) | 87.5 |
| Clopidogrel (%) | 82.6 |
| Ticagrelor (%) | 4.3 |
| β-blocker (%) | 60.9 |
| ACEI/ARB (%) | 52.2 |
| CCB (%) | 4.3 |
| Statin (%) | 95.7 |
Data are mean±SD and n (%).
ACEI/ARB, ACE inhibitors/angiotensin II receptor blockers; BP, blood pressure; CCB, calcium channel blocker; CK, creatine kinase; CKD, chronic kidney disease; CKMB, creatine kinase isoenzyme-B; COPD, chronic obstructive pulmonary disease; EF, ejection fraction; IAPB, intra-aortic balloon pump; IRA, infarct-related artery; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; NSTEMI, non-ST segment elevated myocardial infarction; PLT, platelets; RBC, red blood cell; SPO2, oxyhemoglobin saturation by pulse oximetry; STEMI, ST segment elevated myocardial infarction.